Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.

Antzeko izenburuak

• Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy
  nork: Morton, A R, et al.
  Argitaratua: (1988)
• Bisphosphonates and bone metastases.
  nork: Morton, A. R., et al.
  Argitaratua: (1988)
• Lytic bone metastases after APD in breast carcinoma: Authors' reply
  nork: Howell, A, et al.
  Argitaratua: (1988)
• Lytic bone metastases after APD in breast carcinoma.
  nork: Williams, M. R., et al.
  Argitaratua: (1988)
• Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
  nork: Harinck, H I, et al.
  Argitaratua: (1987)